Cargando…

Complement C3a activates osteoclasts by regulating the PI3K/PDK1/SGK3 pathway in patients with multiple myeloma

OBJECTIVE: Myeloma bone disease (MBD) is the most common complication of multiple myeloma (MM). Our previous study showed that the serum levels of C3/C4 in MM patients were significantly positively correlated with the severity of bone disease. However, the mechanism of C3a/C4a in osteoclasts MM pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Fengjuan, Liu, Hui, Peng, Fengping, Liu, Zhaoyun, Ding, Kai, Song, Jia, Li, Lijuan, Chen, Jin, Shao, Qing, Yan, Siyang, De Veirman, Kim, Vanderkerken, Karin, Fu, Rong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Compuscript 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330530/ https://www.ncbi.nlm.nih.gov/pubmed/33960177 http://dx.doi.org/10.20892/j.issn.2095-3941.2020.0430

Ejemplares similares

CCN1 stimulated the osteoblasts via PTEN/AKT/GSK3β/cyclinD1 signal pathway in Myeloma Bone Disease
por: Yan, Siyang, et al.
Publicado: (2019)

PDK1-SGK1 Signaling Sustains AKT-Independent mTORC1 Activation and Confers Resistance to PI3Kα Inhibition
por: Castel, Pau, et al.
Publicado: (2016)

Roles of LINC01473 and CD74 in osteoblasts in multiple myeloma bone disease
por: Peng, Fengping, et al.
Publicado: (2022)

AKT-independent PI3-K signaling in cancer – emerging role for SGK3
por: Bruhn, Maressa A, et al.
Publicado: (2013)

Functional role of SGK3 in PI3K/Pten driven liver tumor development
por: Cao, Hui, et al.
Publicado: (2019)

Exosomes play a role in multiple myeloma bone disease and tumor development by targeting osteoclasts and osteoblasts
por: Faict, Sylvia, et al.
Publicado: (2018)

Deficient invariant natural killer T cells had impaired regulation on osteoclastogenesis in myeloma bone disease
por: Jiang, Fengjuan, et al.
Publicado: (2018)

AXL Receptor Tyrosine Kinase as a Therapeutic Target in Hematological Malignancies: Focus on Multiple Myeloma
por: Yan, Siyang, et al.
Publicado: (2019)

Mechanism of activation of SGK3 by growth factors via the Class 1 and Class 3 PI3Ks
por: Malik, Nazma, et al.
Publicado: (2018)

Design and Characterization of SGK3-PROTAC1, an Isoform Specific SGK3 Kinase PROTAC Degrader
por: Tovell, Hannah, et al.
Publicado: (2019)

Mesenchymal stem cells in multiple myeloma: a therapeutical tool or target?
por: Xu, Song, et al.
Publicado: (2018)

INPP4B restrains cell proliferation and metastasis via regulation of the PI3K/AKT/SGK pathway
por: Chen, Ying, et al.
Publicado: (2018)

Deficiency of PDK1 in osteoclasts delays fracture healing and repair
por: Xiao, Dongliang, et al.
Publicado: (2020)

The genetic landscape of 5T models for multiple myeloma
por: Maes, Ken, et al.
Publicado: (2018)

In vitro reconstitution of Sgk3 activation by phosphatidylinositol 3-phosphate
por: Pokorny, Daniel, et al.
Publicado: (2021)

Contributions of SGK3 to transporter-related diseases
por: Liao, Qian-Qian, et al.
Publicado: (2022)

Prolonged inhibition of class I PI3K promotes liver cancer stem cell expansion by augmenting SGK3/GSK-3β/β-catenin signalling
por: Liu, Fengchao, et al.
Publicado: (2018)

Loss of Serum and Glucocorticoid-Regulated Kinase 3 (SGK3) Does Not Affect Proliferation and Survival of Multiple Myeloma Cell Lines
por: Hausmann, Stefan, et al.
Publicado: (2015)

The Use of Murine Models for Studying Mechanistic Insights of Genomic Instability in Multiple Myeloma
por: Vlummens, Philip, et al.
Publicado: (2019)

Dexamethasone enhances the lung metastasis of breast cancer via a PI3K-SGK1-CTGF pathway
por: Zhang, Yujing, et al.
Publicado: (2021)

Albumin Stimulates Epithelial Na(+) Transport and Barrier Integrity by Activating the PI3K/AKT/SGK1 Pathway
por: Laube, Mandy, et al.
Publicado: (2022)

The Epigenome in Multiple Myeloma: Impact on Tumor Cell Plasticity and Drug Response
por: De Smedt, Eva, et al.
Publicado: (2018)

CDK1-PDK1-PI3K/Akt signaling pathway regulates embryonic and induced pluripotency
por: Wang, Xiao Qi, et al.
Publicado: (2017)

MiR-155 promotes epithelial-mesenchymal transition in hepatocellular carcinoma cells through the activation of PI3K/SGK3/β-catenin signaling pathways
por: Kong, Xin, et al.
Publicado: (2016)

Aberrant DNA methylation in multiple myeloma: A major obstacle or an opportunity?
por: Muylaert, Catharina, et al.
Publicado: (2022)

The hVps34‐SGK3 pathway alleviates sustained PI3K/Akt inhibition by stimulating mTORC1 and tumour growth
por: Bago, Ruzica, et al.
Publicado: (2016)

Metabolic cross-talk within the bone marrow milieu: focus on multiple myeloma
por: Oudaert, Inge, et al.
Publicado: (2022)

L-plastin Ser5 phosphorylation is modulated by the PI3K/SGK pathway and promotes breast cancer cell invasiveness
por: Machado, Raquel A. C., et al.
Publicado: (2021)

Naomaitai Ameliorated Brain Damage in Rats with Vascular Dementia by PI3K/PDK1/AKT Signaling Pathway
por: Huang, Kui, et al.
Publicado: (2019)

CaMKK2 Promotes the Progression of Ovarian Carcinoma through the PI3K/PDK1/Akt Axis
por: Chen, Zhen, et al.
Publicado: (2022)

Adiponectin inhibits the differentiation and maturation of osteoclasts via the mTOR pathway in multiple myeloma
por: Liu, Zhaoyun, et al.
Publicado: (2020)

Epigenetic treatment of multiple myeloma mediates tumor intrinsic and extrinsic immunomodulatory effects
por: De Beck, Lien, et al.
Publicado: (2018)

HPV E7-mediated NCAPH ectopic expression regulates the carcinogenesis of cervical carcinoma via PI3K/AKT/SGK pathway
por: Wang, Meng, et al.
Publicado: (2020)

Lethality of PAK3 and SGK2 shRNAs to Human Papillomavirus Positive Cervical Cancer Cells Is Independent of PAK3 and SGK2 Knockdown
por: Zhou, Nannan, et al.
Publicado: (2015)

Contribution of Natural Inhibitors to the Understanding of the PI3K/PDK1/PKB Pathway in the Insulin-mediated Intracellular Signaling Cascade
por: Cho, Jae Youl, et al.
Publicado: (2008)

Retracted: CaMKK2 Promotes the Progression of Ovarian Carcinoma through the PI3K/PDK1/Akt Axis
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Neoalbaconol induces energy depletion and multiple cell death in cancer cells by targeting PDK1-PI3-K/Akt signaling pathway
por: Deng, Q, et al.
Publicado: (2013)

miR-23b-3p regulates differentiation of osteoclasts by targeting PTEN via the PI3k/AKT pathway
por: Chai, Jiwei, et al.
Publicado: (2019)

Dimethyl Cardamonin Exhibits Anti-inflammatory Effects via Interfering with the PI3K-PDK1-PKCα Signaling Pathway
por: Yu, Wan-Guo, et al.
Publicado: (2015)

EGFR-PI3K-PDK1 pathway regulates YAP signaling in hepatocellular carcinoma: the mechanism and its implications in targeted therapy
por: Xia, Hongwei, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5q5qlm9spqp5gd616gc2q9lvcp